As the world continues to adapt to the global public health situation, Gene Therapy for Neurological Disorders Europe virtually unites leading decision-makers from large pharma and biotechs to tackle and explore the key challenges facing translational drug development in gene therapy for neurological disorders.
Bringing together the whos-who of the industry, this meeting allows you to connect online with
thought-leaders to collaboratively overcome the field’s challenges and find improved solutions.
We'll work with you to build a bespoke partnership package centred around making valuable connections and generating actionable leads to ensure you meet your 2020 commercial objectives in this new digital reality.
- Showcase your expertise to leading organisations by securing a virtual
- Secure a spot on our expert speaker faculty to demonstrate thought leadership
and drive brand exposure
- Maximise the balance of 2:1 live content and targeted online networking to
generate leads and build new relationships with gene therapy pioneers
- Embrace the tech to meet your 2020 commercial objectives and educate decision
makers on how your expertise can deliver gene therapies to patients more effectively